Replies to post #12 on Horizon Therapeutics Public Limited Co (fka HZNP)

[surf1944]

7:02AM Horizon Pharma enters into exclusive agreement with Mundipharma for commercialization of LODOTRA in Latin America (HZNP) 3.33 : Co announced that its Swiss subsidiary and Mundipharma International Corporation Limited and Mundipharma Medical Company have amended their exclusive distribution and supply agreements for commercialization of LODOTRA, a proprietary, programmed-release formulation of low-dose prednisone, in Asia to also include Mexico, Brazil, Argentina, Colombia, Venezuela, Peru, Chile, Ecuador, Dominican Republic, Guatemala, Costa Rica, Uruguay, Bolivia, Panama, Nicaragua, El Salvador and Honduras.